Long-Acting HIV Treatment Failure Can Limit Future Options
Summary
Although virologic failure is uncommon with long-acting injectable HIV treatment, resistance can compromise future treatment options, particularly with dolutegravir and bictegravir.
Description from Medscape.
Who is covering this
-
Long-Acting HIV Treatment Failure Can Limit Future Options
Although virologic failure is uncommon with long-acting injectable HIV treatment, resistance can compromise future treatment options, particularly with dolutegravir and bictegravir.
Comments
Comments need JavaScript.